PDF Cover

IV Tubing Sets And Accessories Market

The market for IV Tubing Sets And Accessories was estimated at $1.5 billion in 2025; it is anticipated to increase to $2.0 billion by 2030, with projections indicating growth to around $2.8 billion by 2035.

Report ID:DS1806032
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Other Healthcare
IV Tubing Sets And Accessories
Share
Report Summary
Market Data
Methodology
Table of Contents

Global IV Tubing Sets And Accessories Market Outlook

Revenue, 2025

$1.5B

Forecast, 2035

$2.8B

CAGR, 2026 - 2035

6.3%

The IV Tubing Sets And Accessories industry revenue is expected to be around $1.5 billion in 2026 and expected to showcase growth with 6.3% CAGR between 2026 and 2035. With the backdrop of expanding surgical volumes and the increasing burden of chronic and infectious diseases, IV Tubing Sets And Accessories have become a critical item in hospital IV supplies and for infusion therapy. This is due to a global shift in IV administration protocols to evidence based methods and ones standardised. With an increasing demand in the medical sector for IV delivery systems, the healthcare industry is in need of IV equipment that performs flawlessly. This is particularly important in emergency care and intensive care units. These devices are used in 67.9% of all applications either for peripheral IV infusion or central venous infusion, demonstrating their importance in both treatment and maintenance of health. In the year 2025, the sales for primary IV tubing sets reached approximately $0.66 billion, this demonstrates the strong position that primary IV tubing holds within the IV Tubing Sets and Accessories product range and its continued use in acute care and home infusion therapy. IV Tubing Sets and Accessories comprise a range of products including primary IV tubing, secondary IV sets, needleless connectors, stopcocks, filters, extension lines and IV fluid regulators. These products enable healthcare professionals to administer fluids, blood, nutrients and medication through IV lines in patients veins.

Modern IV tubing sets often have several beneficial features. These include the use of materials that are biocompatible and free from DEHP. Tubing sets are also designed to withstand pressure without collapsing and they resist kinking. Additionally, IV systems allow for precise control of the flow rate. This group of IV administration sets have applications across a number of key sectors including chemotherapy, parenteral nutrition, central and peripheral IV infusion and critical care. Additionally IV anaesthesia is another region of use. There is growing demand for IV infusions from home and outpatient care, which in turn drives demand for IV accessories. The IV therapy sector is experiencing various market trends. Closed and needleless IV infusion systems, low adsorption and antimicrobial IV fluid line technologies are being increasingly adopted. There is also greater standardisation of IV products across hospitals. In addition, there is a preference for single use IV tubes which aid in infection control and reduce operating costs.

IV Tubing Sets And Accessories market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
IV Tubing Sets And Accessories Market Outlook

Market Key Insights

  • The IV Tubing Sets And Accessories market is projected to grow from $1.5 billion in 2025 to $2.8 billion in 2035. This represents a CAGR of 6.3%, reflecting rising demand across Peripheral IV Infusion, Central Venous Infusion, and PICC Line Infusion.

  • The industry is dominated by seven main players. B. Braun Medical and Baxter hold the largest market shares within the industry.

  • The US and German markets are anticipated to lead the IV Tubing Sets and Accessories industry in terms of revenue generation. By 2030, these two markets are expected to achieve growth rates ranging from 4.1 to 6 per cent annually.

  • The highest growth rates are expected to be observed in the emerging markets of India, Brazil and Mexico, with a Compound Annual Growth Rate between 7.2% and 8.7%.

  • Future investment into disposable IV tubing sets may be prompted by the industry due to existing growth rates of 6.3%. This is expected to be supported with $65 million by 2030.

  • Over the period 2025 2035, it is predicted that IV Tubing Sets and Accessories will increase by $1.3 billion. Central venous infusion and peripherally inserted central catheter line infusion are projected to be of particular interest in this market.

  • With

    growing chronic disease prevalence and expansion of home healthcare services, and

    Technological Advancements in Smart IV Tubing and Safety Enhancements, IV Tubing Sets And Accessories market to expand 84% between 2025 and 2035.

iv tubing sets and accessories market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
IV Tubing Sets And Accessories - Country Share Analysis

Opportunities in the IV Tubing Sets And Accessories

Healthcare providers across Europe are concentrating on selecting IV tubing sets and infusion pump systems that are compatible to reduce errors with medicines. The growing demand for IV tubes is leading to increased sales of IV tube fittings and also associated products such as anti kinking IV tube fittings. The IV tubing accessories market is expected to grow from $0.25 billion in 2014 to $0.35 billion by 2030. Suppliers who develop IV tubing products which are compatible with existing IV pumps by collaborating with the pump manufacturers can secure multi year contracts.

Growth Opportunities in North America and Asia-Pacific

In North America, intravenous tubing and related items have a demand mainly driven by central venous infusion and PICC line treatments. The key driver behind this demand is in the medical sector, particularly for oncology patients and other patients who require high levels of care. Such patients often require long term intravenous therapy. Key region's for growth lie in hospital consumables with premium safety features such as needle free connectors and which also possess anti microbial properties. These goods align with health facility infection control policies as well as value based purchasing procedures used by health networks. With global brand and group purchasing organisation owned private label companies placing such intense pressure on suppliers, it is now essential for these suppliers to compete. This is through provision of clinical evidence, supply chains resilient to disruption and secure infusion equipment. The trend towards treating patients in a home setting and ambulatory care is becoming increasingly prominent in the region, as are the numbers of those using outpatient cancer treatment facilities. Complex infusion services are also seeing a greater level of reimbursement, which may benefit suppliers who are able to offer IV tube sets along with digital traceability and inventory tracking systems. Companies should focus on having a diverse range of products which can be used alongside central venous and PICC lines. They should also look into the cost effectiveness of their products to increase their chances of being selected by healthcare providers. Manufacturers should also look to work alongside larger healthcare providers to secure long term supply contracts.
Across Asia Pacific, IV tubing sets and accessories market development is mainly influenced by peripheral IV infusions. This can be attributed to rapid development in hospital infrastructure and an increase in surgical operations. Emerging markets also have more access to standard infusion treatments. Central venous and PICC applications are expanding from these tertiary care centres. The greatest possibilities in the field are IV infusion kits and other healthcare equipment which are made in large quantities and are also low cost. These products must offer a good level of quality and should be packaged and manufactured in line with the specific needs of the government and private healthcare businesses. The market in this sector is extremely fragmented with a number of different manufacturers, some of which are regional and others are domestic, all competing with one another by pricing goods low and also by making sure that products are relevant to the local region. This leads to foreign firms being forced to differentiate themselves through consistent quality, complying with local laws, training employees, and being a reliable supplier when there is a surge in demand. Key drivers of growth include a heightened awareness of hospital acquired infections, universal health care and government initiatives to increase critical care facilities, and the need for safety devices for intravenous fluids. Companies should diversify their product lines and focus on providing different products for different target markets by creating high, medium and low cost IV infusion sets. They should focus on selling high value products to clients in large cities through established businesses and manufacturers in these region's. This will increase sales to clients in urban regions.

Market Dynamics and Supply Chain

01

Driver: Growing Chronic Disease Prevalence and Expansion of Home Healthcare Services

The IV tubing sets and accessories market is also driven by rising chronic disease prevalence and expanding home healthcare services, which together increase demand for reliable intravenous therapies. Chronic conditions such as diabetes, cardiovascular disease, and cancer often require long‑term IV treatments, boosting the use of IV tubing systems in hospitals and infusion centers. Simultaneously, the global shift toward home‑based care-especially among aging populations and chronic patients-fuels adoption of user‑friendly IV tubing sets designed for outpatient and at‑home infusion, enhancing convenience, reducing hospital stays, and expanding overall market demand. As care decentralizes and home infusion becomes more common, manufacturers benefit from broader application volumes and diversified distribution channels. 
A key driver for the IV tubing sets and accessories market is also technological innovation, particularly the development of smart IV tubing systems and safety‑focused accessories. New features like integrated sensors, needleless connectors, anti‑kink tubing, and real‑time flow monitoring improve patient safety, reduce infection risk, and enhance infusion accuracy. These advancements resonate with modern healthcare protocols prioritizing infection control and clinical efficiency, encouraging hospitals and home care providers to adopt advanced tubing systems that align with digital health and infusion pump integration.
02

Restraint: Stringent Regulatory Compliance and High Production Costs Hinder Market Innovation and Growth

The IV tubing sets and accessories market is restrained by stringent regulatory requirements that increase development timelines and compliance costs for manufacturers. Agencies like the FDA and EMA require extensive testing and documentation before product approval, delaying new product launches and hampering innovation. These regulatory hurdles raise production costs, which in turn restrict adoption in cost‑sensitive regions, slow expansion into emerging markets, and compress profit margins, limiting overall market revenue growth.
03

Opportunity: Indian private hospital critical care expansion unlocks demand for advanced Iv Tubing Sets And Accessories and US home infusion growth among seniors creates major opportunity for Iv Tubing Sets And Accessories

The rapidly expanding healthcare infrastructure within India is particularly focused on the improvement of critical care facilities, however, IV tubes and associated accessories continue to be a largely underdeveloped market, especially outside the larger cities. The need for intravenous products will be driven by the increasing patient volume in the hospitals emergency department and the ICU. By 2030 it is predicted that global sales of primary IV tubing sets will rise from $0.66 billion to $0.87 billion, providing opportunities for those who manufacture the product to localise production, secure contracts with hospitals by negotiating a better price and to tie up with hospital groups for long term deals.
The US home infusion therapy industry is placing greater emphasis on treating conditions such as heart failure and cancer and long term antibiotic treatments at home. This segment covers IV extension sets and primary IV sets which are compatible with portable infusion pumps and also solutions for infection control. By 2030, it is predicted that IV extension sets will rise from $0.19 billion to $0.27 billion globally. Companies which supply user friendly IV extension sets and which provide training for caregivers are likely to meet an underserved need in this market which is driven by the reimbursement of medical treatment.
04

Challenge: Infection Risks, Product Recalls, and Safety Concerns Reduce Clinical Adoption Rates

Another significant restraint is the risk of catheter‑related bloodstream infections (CRBSIs) and product safety issues tied to IV tubing use. Cases of infection or defects such as leaks and flow malfunctions lead to patient harm and product recalls, undermining clinician confidence and discouraging uptake of advanced tubing systems. Healthcare facilities become cautious about investing in new products after recalls, which suppresses demand, increases operational costs, and impacts market dynamics negatively.

Supply Chain Landscape

1

Raw Materials

Baxter InternationalNipro
2

IV Set Manufacturing

B. Braun Medical Inc.Polymedicure
3

Accessory Assembly

Zyno Medical LLCICU Medical
4

Clinical End Use

HospitalsAmbulatory Surgical CentersHome Healthcare
IV Tubing Sets And Accessories - Supply Chain

Use Cases of IV Tubing Sets And Accessories in Peripheral IV Infusion & PICC Line Infusion

Peripheral IV Infusion : Peripheral IV infusion relies heavily on IV tubing sets and accessories such as primary and secondary IV tubing sets, extension sets, needleless connectors, and infusion accessories to deliver fluids, medications, and electrolytes through peripheral intravenous catheters efficiently and safely in hospitals and ambulatory care settings. These products enhance infusion accuracy, reduce contamination risk, and support rapid fluid administration during hydration therapy, antibiotic delivery, and emergency care. Leading players like Becton Dickinson (BD), B. Braun Melsungen AG, ICU Medical, Inc., Fresenius Kabi, and Baxter International offer robust, high‑quality tubing solutions with safety features such as anti‑kink lines and needleless connectors, reinforcing their strong market positions through extensive global distribution and innovation in infection‑prevention design.
Central Venous Infusion : Central venous infusion relies on specialized IV tubing sets and accessories that connect central venous catheters to fluid or medication sources, ensuring safe and controlled delivery of intravenous therapies in critical care and surgical settings. Primary and extension IV tubing sets with luer‑lock connectors, pressure‑resistant lines, and anti‑kink features are commonly used in hospitals and intensive care units to maintain continuous infusion and minimize complications. Leading players like Becton Dickinson (BD), B. Braun Melsungen AG, ICU Medical, Fresenius Kabi, and Baxter International provide high‑quality, infection‑resistant tubing systems with integrated safety components, strengthening their positions through robust distribution networks and clinical reliability in central venous access applications.
PICC Line Infusion : PICC line infusion relies on IV tubing sets and accessories such as specialized PICC extension tubing, anti‑reflux valves, secure needleless connectors, clamps, and sterile extension sets that support long‑term intravenous access for therapies like antibiotics, chemotherapy, and parenteral nutrition, especially in hospitals and outpatient infusion centers. These sets enhance catheter stability, reduce infection risk, and enable precise fluid delivery for prolonged treatments. Leading suppliers including Baxter International, Becton Dickinson (BD), ICU Medical, B. Braun Melsungen, and Fresenius Kabi provide high‑quality, pump‑compatible IV tubing and accessory portfolios with strong clinical support and global distribution, reinforcing their positions across acute care and long‑term infusion applications.

Recent Developments

Recent developments in the IV tubing sets and accessories industry reflect growing emphasis on safety, smart infusion technology, and digital healthcare integration. Manufacturers are launching needleless and DEHP‑free tubing sets to reduce catheter‑related infections and improve patient safety, aligning with rising infection control standards in hospitals. Adoption of smart IV systems with real‑time flow monitoring and integration with infusion pumps and electronic health records supports more precise and efficient intravenous therapy. A key market trend is the shift toward automated, sensor‑enabled tubing and advanced connectors that enhance clinical outcomes, reduce medication errors, and support home infusion and outpatient care models, driving wider adoption across healthcare settings.

September 2024 : B. Braun Medical Inc. secured FDA 510(k) clearance for its Introcan Safety 2 Deep Access IV Catheter, enhancing vascular access performance with improved dwell times and advanced safety features, reinforcing its portfolio in IV administration and patient safety solutions.
July 2024 : Fresenius Kabi announced a manufacturing expansion in India for IV tubing sets to meet rising demand across the Asia Pacific region, strengthening its regional production capacity and supply chain footprint.
January 2025 : ICU Medical, Inc. launched a closed system IV tubing set series designed to enhance safety in critical care and chemotherapy infusion environments by reducing contamination risks, boosting its critical care product offerings.

Impact of Industry Transitions on the IV Tubing Sets And Accessories Market

As a core segment of the Other Healthcare industry, the IV Tubing Sets And Accessories market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Disposable IV Tubing Sets and Expansion from Hospital Use to Home and Outpatient Care have redefined priorities across the Other Healthcare sector, influencing how the IV Tubing Sets And Accessories market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift towards Disposable IV Tubing Sets

The IV tubing sets and accessories sector is in the process of a shift towards the IV tubings which are disposable in nature. This is because there is an increasing concern among healthcare professionals over cross infection, a reduction in cross contamination and stronger patient protection policies. At present the sectors growth rate stands at 6.3% but firms within the industry are actively working towards increasing this with the marketing of single use IV tubing as well as the relevant accessories. Some $65 million in investments are set to be committed to this strategy by the year 2030, enhancing and increasing production capability, and also stimulating new and innovative products for disposable medical products. The reallocation of resources reflects a change in competitive market positioning where suppliers with low cost products for infection control IV equipment will capture market growth and establish long term standards in the market.
02

Expansion from Hospital Use to Home and Outpatient Care

Another major industry shift is the growing adoption of IV tubing sets in home healthcare and outpatient infusion services. Aging populations and chronic disease prevalence are driving the need for long-term intravenous therapies outside hospitals, including chemotherapy, antibiotics, and parenteral nutrition. Manufacturers are responding with compact, easy-to-use, and sterile-ready tubing sets suitable for patient self-administration or caregiver support. This transition is influencing home healthcare logistics, telemedicine, and infusion service models, enabling decentralized care, reducing hospital stays, and expanding market reach to previously underserved patient populations.